MetaADEDB 2.0 @ LMMD
9,10-Dimethyl-1,2-benzanthracene
(ARSRBNBHOADGJU-UHFFFAOYSA-N)
Structure
SMILES
Cc1c2ccc3c(c2c(c2c1cccc2)C)cccc3
Molecular Formula:
C20H16
Molecular Weight:
256.341
Log P:
5.7630
Hydrogen Bond Acceptor:
0
Hydrogen Bond Donor:
0
TPSA:
0
CAS Number(s):
57-97-6
Synonym(s)
1.
9,10-Dimethyl-1,2-benzanthracene
2.
7,12-Dimethylbenzanthracene
3.
7,12-Dimethylbenz(a)anthracene
4.
7,12 Dimethylbenzanthracene
External Link(s)
MeSHD015127
PubChem Compound6001
ChEBI254496
CHEMBLCHEMBL329673
KEGGcpd:C19488
ZINC1600920
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Adenocarcinoma

View details

CTD
2Adenoma11376689
21398560
CTD
3Arteriosclerosis3142695CTD
4Carcinoma

View details

CTD
5Chemical and Drug Induced Liver Injury21037200CTD
6Chromosome Breakage29502735CTD
7Edema14972014CTD
8Fetal Growth Retardation23656968CTD
9Genomic Instability21527772CTD
10Hyperplasia

View details

CTD
11Inflammation14972014
23835587
CTD
12Kidney Diseases24995432CTD
13Liver Neoplasms, Experimental1399818
21092749
CTD
14Liver neoplasms9643874CTD
15Lung Neoplasms11376689CTD
16Lymphoma10051580
11376689
CTD
17Mammary Neoplasms, Experimental

View details

CTD
18Micronuclei, Chromosome-Defective7556107CTD
19Mouth Neoplasms

View details

CTD
20Neoplasm Invasiveness29663660CTD
21Neoplasms, Experimental

View details

CTD
22Neoplasms11544531
22485181
CTD
23Neural Tube Defects23656968CTD
24Ovarian Diseases

View details

CTD
25Papilloma

View details

CTD
26Precancerous Conditions

View details

CTD
27Prenatal Exposure Delayed Effects11394711CTD
28Prostatic Neoplasms2105161
2137026
CTD
29Skin Neoplasms

View details

CTD
30fibroma21398560CTD
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120242

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.